Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria.
Infect Immun
; 88(2)2020 01 22.
Article
in En
| MEDLINE
| ID: mdl-31740525
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vaccinia virus
/
Recombinant Fusion Proteins
/
Drug Carriers
/
Adenoviruses, Simian
/
Malaria Vaccines
/
Malaria
/
Antigens, Protozoan
Type of study:
Guideline
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Infect Immun
Year:
2020
Type:
Article
Affiliation country:
United kingdom